Association between the p53 codon 72 Arg/Pro polymorphism and hepatocellular carcinoma risk
- PDF / 281,977 Bytes
- 9 Pages / 595.276 x 790.866 pts Page_size
- 85 Downloads / 169 Views
RESEARCH ARTICLE
Association between the p53 codon 72 Arg/Pro polymorphism and hepatocellular carcinoma risk Long Lv & Ping Wang & Xiaoqing Zhou & Beicheng Sun
Received: 23 November 2012 / Accepted: 3 January 2013 / Published online: 6 April 2013 # International Society of Oncology and BioMarkers (ISOBM) 2013
Abstract Previous studies regarding the association of p53 codon 72 Arg/Pro polymorphism with hepatocellular carcinoma (HCC) risk have provided conflicting and inconclusive findings. Thus, a meta-analysis of all currently available publications was performed to address this issue. Eleven individual case–control studies involving a total of 2,718 cases and 3,752 controls were identified after a systematic search of the PubMed, Embase, Web of Science, and Wanfang databases. The strength of the association of p53 codon 72 Arg/Pro polymorphism with HCC risk was estimated by the pooled odds ratio (OR) with its corresponding 95 % confidence interval (95 % CI). Subgroup analyses stratified by ethnicity, source of controls, gender, hepatitis virus infection status, and family history of HCC were also conducted to assess the association. Overall, significantly increased risk of HCC was identified among carriers of the homozygous genotype ProPro (ORProPro vs. ArgArg =1.38 (95 % CI, 1.03–1.85), POR =0.033; ORProPro vs. ArgArg + ArgPro =1.28 (95 % CI, 1.03–1.59), POR =0.026). In subgroup analysis by ethnicity, the pooled results suggested that the p53 codon 72 Arg/Pro polymorphism was associated with an increased risk of HCC in Asians and Caucasians (for Asians, ORProPro vs. ArgArg + ArgPro =1.17 (95 % CI, 1.02– 1.34), POR =0.025; for Caucasians, ORProPro vs. ArgArg =1.65 L. Lv : B. Sun (*) Liver Transplantation Center, The First Affiliated Hospital of Nanjing Medical University, No. 300 Guangzhou Road, Nanjing 210029 Jiangsu Province, China e-mail: [email protected] P. Wang Department of Internal Medicine, People’s Hospital of Gaochun, Gaochun 211300 Jiangsu Province, China L. Lv : X. Zhou (*) Department of General Surgery, People’s Hospital of Gaochun, No. 9 Chunzhong Road, Gaochun 211300 Jiangsu Province, China e-mail: [email protected]
(95 % CI, 1.07–2.56), POR =0.025; ORProPro vs. ArgArg + ArgPro =1.74 (95 % CI, 1.14–2.66), POR =0.010). Subgroup analyses by source of controls and hepatitis virus infection status further demonstrated the significant association, whereas stratification factors involving gender and family history of HCC did not modify the association between p53 codon 72 Arg/Pro polymorphism and HCC risk. This meta-analysis suggests that the p53 codon 72 Arg/Pro polymorphism may play a critical role in the development of HCC, and gender and family history of HCC may not modulate the effect of p53 codon 72 Arg/Pro in HCC risk. Keywords P53 codon 72 . Hepatocellular carcinoma . Polymorphisms . Meta-analysis
Introduction Hepatocellular carcinoma (HCC), as the most frequent primary cancer of the liver, is the sixth most common cancer and the third most common cause of cancerrelated de
Data Loading...
